Product: Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY  10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL  61103, NDC 67457-467-99.
Reason for recall: Presence of Particulate Matter
Recall initiated: 20150318
Status: Terminated
Classification: Class I
Recall type: Voluntary: Firm initiated